Unlock your academic potential and expand your network by joining us!

institution avatar image

University of Bari Aldo Moro

Education
39491 Publications
226 Members
Latest Publications
Journal Article
Endocrine, Metabolic & Immune Disorders - Drug Targets
Published: 01 January 2025 in Endocrine, Metabolic & Immune Disorders - Drug Targets
ACS Style

Emilio Jirillo. Preface. Endocrine, Metabolic & Immune Disorders - Drug Targets 2025, 25, 1 -1.

AMA Style

Emilio Jirillo. Preface. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2025; 25 (1):1-1.

Chicago/Turabian Style

Emilio Jirillo. 2025. "Preface." Endocrine, Metabolic & Immune Disorders - Drug Targets 25, no. 1: 1-1.

Journal Article
Endocrine, Metabolic & Immune Disorders - Drug Targets
Published: 01 December 2024 in Endocrine, Metabolic & Immune Disorders - Drug Targets

: Panax ginseng is one of the most important remedies in ancient Eastern medicine. In the modern Western world, its reputation started to grow towards the end of the XIX century, but the rather approximate understanding of action mechanisms did not provide sufficient information for an appropriate use. Nowadays, Panax ginseng is frequently used in some pathological conditions, but the comprehension of its potential beneficial effects is still incomplete. The purpose of this study is to highlight the most recent knowledge on mechanisms and effects of ginseng active ingredients on the intestinal microbiota. The human microbiota takes part in the immune and metabolic balance and serves as the most important regulator for the control of local pathogens. This delicate role requires a complex interaction and reflects the interconnection with the brain- and the liver-axes. Thus, by exerting their beneficial effects through the intestinal microbiota, the active ingredients of Panax ginseng (glycosides and their metabolites) might help to ameliorate both specific intestinal conditions as well as the whole organism's homeostasis.

ACS Style

Monica Montagnani; Maria Assunta Potenza; Massimo Corsalini; Giuseppe Barile; Ioannis Alexandros Charitos; Andrea De Giacomo; Emilio Jirillo; Marica Colella; Luigi Santacroce. Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity of Panax ginseng. A Scoping Review. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024, 24, 1756 -1773.

AMA Style

Monica Montagnani, Maria Assunta Potenza, Massimo Corsalini, Giuseppe Barile, Ioannis Alexandros Charitos, Andrea De Giacomo, Emilio Jirillo, Marica Colella, Luigi Santacroce. Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity of Panax ginseng. A Scoping Review. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2024; 24 (15):1756-1773.

Chicago/Turabian Style

Monica Montagnani; Maria Assunta Potenza; Massimo Corsalini; Giuseppe Barile; Ioannis Alexandros Charitos; Andrea De Giacomo; Emilio Jirillo; Marica Colella; Luigi Santacroce. 2024. "Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity of Panax ginseng. A Scoping Review." Endocrine, Metabolic & Immune Disorders - Drug Targets 24, no. 15: 1756-1773.

Journal Article
Endocrine, Metabolic & Immune Disorders - Drug Targets
Published: 01 December 2024 in Endocrine, Metabolic & Immune Disorders - Drug Targets
ACS Style

Luigi Santacroce; Skender Topi; Kazuki Santa; Isao Nagaoka; Emilio Jirillo; Yoshio Kumazawa. Mediterranean and Japanese Diets as Promoters of Wellbeing and Longevity: Commonalities and Differences. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024, 24, 1709 -1710.

AMA Style

Luigi Santacroce, Skender Topi, Kazuki Santa, Isao Nagaoka, Emilio Jirillo, Yoshio Kumazawa. Mediterranean and Japanese Diets as Promoters of Wellbeing and Longevity: Commonalities and Differences. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2024; 24 (15):1709-1710.

Chicago/Turabian Style

Luigi Santacroce; Skender Topi; Kazuki Santa; Isao Nagaoka; Emilio Jirillo; Yoshio Kumazawa. 2024. "Mediterranean and Japanese Diets as Promoters of Wellbeing and Longevity: Commonalities and Differences." Endocrine, Metabolic & Immune Disorders - Drug Targets 24, no. 15: 1709-1710.

View all